Azurity Prescription drugs Proclaims the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Resolution, CII
Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Prescription drugs, Inc.…
ER2 Improves Ecommerce Success National with Descartes Resolution
ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Descartes Techniques Team (Nasdaq:DSGX) (TSX:DSG),…
Snyk Launches Agent Safety Strategy to Offer protection to the Complete AI Lifecycle; Pronounces Basic Availability of Evo AI-SPM
SAN FRANCISCO, March 23, 2026 (GLOBE NEWSWIRE) -- Snyk, the AI safety…
